Andrew Dennis
About Andrew Dennis
Andrew Dennis is the Director of Drug Product Science & Technology at Bristol-Myers Squibb, with over 30 years of experience in the pharmaceutical industry.
Current Role as Director Drug Product Science & Technology
Andrew Dennis is the Director of Drug Product Science & Technology at Bristol-Myers Squibb, located in Moreton, UK. He has held this position since May 2016. In his role, he oversees the development and formulation of drug products, leveraging his extensive background in pharmaceutics and drug product technology to drive innovation and ensure the efficacy and safety of pharmaceutical products.
Previous Role as Associate Director at Bristol-Myers Squibb
Prior to his current managerial role, Andrew Dennis served as an Associate Director at Bristol-Myers Squibb. During his tenure in this position, he contributed significantly to the field of pharmaceutics, focusing on the formulation and testing of various drug products. His work in this capacity helped lay the groundwork for his subsequent promotion to Director.
Educational Background in Pharmaceutics and Pharmacy
Andrew Dennis completed his PhD in Pharmaceutics at the University of Wales, Cardiff, graduating in 1987 after three years of rigorous research and study. Before that, he earned a B.Pharm degree from the University of Bath in 1983. His academic background has provided him with a strong foundation in pharmaceutical sciences, which he continues to apply in his professional career.
Over 30 Years of Experience in the Pharmaceutical Industry
With over 30 years of experience in the pharmaceutical industry, Andrew Dennis brings a wealth of knowledge and expertise to his role at Bristol-Myers Squibb. His extensive career encompasses various aspects of drug product science and technology, contributing to the development of effective and safe pharmaceutical products.